Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The . gov means it’s official. Federal government websites often end in . gov or . mil. Before sharing sensitive information, make sure you’re on a federal government site. VSports app下载.

Https

The site is secure V体育官网. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. .

. 2019 Feb 4:2019:3140204.
doi: 10.1155/2019/3140204. eCollection 2019.

Serum Leucine-Rich α 2-Glycoprotein as a Biomarker for Monitoring Disease Activity in Patients with Systemic Juvenile Idiopathic Arthritis (VSports最新版本)

Affiliations

Serum Leucine-Rich α 2-Glycoprotein as a Biomarker for Monitoring Disease Activity in Patients with Systemic Juvenile Idiopathic Arthritis

Masaki Shimizu et al. J Immunol Res. .

VSports - Abstract

To investigate whether serum leucine-rich α2-glycoprotein (LRG) levels are useful as a marker of disease activity in systemic juvenile idiopathic arthritis (s-JIA), we determined serum LRG levels in fifty-nine s-JIA patients, 15 with other subtypes of JIA, 7 with Kawasaki disease (KD), 7 with influenza A infection (flu), 7 with enterohemorrhagic Escherichia coli (EHEC) infection, and 20 healthy controls (HC). Results were compared with the clinical features of s-JIA and serum cytokine levels including interleukin- (IL-) 6, IL-18, and soluble tumor necrosis factor receptors I and II. Serum LRG levels in active s-JIA were higher compared to those in other subtypes of JIA, EHEC, flu patients, and HC VSports手机版. Serum LRG levels were normalized in the inactive s-JIA phase after treatment. Serum LRG levels were positively correlated with serum C-reactive protein and ferritin levels. Serum LRG levels reflected s-JIA disease activity and thus may be useful for monitoring s-JIA disease activity. .

PubMed Disclaimer

Figures

Figure 1
Figure 1
Serum levels of LRG in patients with s-JIA and other various diseases. Bars represent median values. Statistically significant differences between each patient group are shown as p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.01, and ∗∗∗∗p < 0.0001. LRG: leucine-rich α2-glycoprotein; s-JIA: systemic juvenile idiopathic arthritis; RF+ polyJIA: rheumatoid factor-positive polyarticular JIA; oligoJIA: oligoarticular JIA; ERA: enthesitis-related arthritis; KS: Kawasaki disease; flu: influenza A infection; EHEC: enterohemorrhagic Escherichia coli infection; HC: healthy controls.
Figure 2
Figure 2
Changes in serum LRG in patients with s-JIA. (a) Serum LRG levels in each s-JIA phase are shown. (b) Changes in serum LRG level are shown. Statistically significant differences between each patient group are shown as ∗∗p < 0.01, ∗∗∗p < 0.01, and ∗∗∗∗p < 0.0001. LRG: leucine-rich α2-glycoprotein.
Figure 3
Figure 3
Correlations between serum LRG levels and other measures of disease activity. Serum LRG levels were compared with other serum biomarker levels in s-JIA patients. (a) CRP, (b) ferritin, (c) AST, (d) LDH, (e) IL-6, (f) IL-18, (g) sTNFRI, and (h) sTNFRII. Black boxes indicate the values in s-JIA patients. LRG: leucine-rich α2-glycoprotein; CRP: C-reactive protein; AST: aspartate aminotransferase; LDH: lactate dehydrogenase; IL: interleukin; sTNFR: soluble tumor necrosis factor receptor.

References

    1. Mellins E. D., Macaubas C., Grom A. A. Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions. Nature Reviews Rheumatology. 2011;7(7):416–426. doi: 10.1038/nrrheum.2011.68. - DOI - PMC - PubMed
    1. Urushima H., Fujimoto M., Mishima T., et al. Leucine-rich alpha 2 glycoprotein promotes Th17 differentiation and collagen-induced arthritis in mice through enhancement of TGF-β-Smad2 signaling in naïve helper T cells. Arthritis Research & Therapy. 2017;19(1):p. 137. doi: 10.1186/s13075-017-1349-2. - "V体育官网入口" DOI - PMC - PubMed
    1. Wang X., Abraham S., McKenzie J. A. G., et al. LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling. Nature. 2013;499(7458):306–311. doi: 10.1038/nature12345. - DOI - PMC - PubMed
    1. O’Donnell L. C., Druhan L. J., Avalos B. R. Molecular characterization and expression analysis of leucine-rich α2-glycoprotein, a novel marker of granulocytic differentiation. Journal of Leukocyte Biology. 2002;72(3):478–485. - PubMed (V体育安卓版)
    1. Serada S., Fujimoto M., Terabe F., et al. Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis. Inflammatory Bowel Diseases. 2012;18(11):2169–2179. doi: 10.1002/ibd.22936. - DOI - PubMed

MeSH terms